Today's Health Winners and Losers
NitroMed (NTMD) shares slid 17% after the drugmaker posted fourth-quarter results that fell short of expectations. The company reported a loss of $31.6 million, or $1.04 a share, on sales of $3.7 million. Analysts expected a smaller loss of 94 cents a share, with sales of $4.35 million. A year earlier, the company had a loss of $9.7 million, or 36 cents a share, on sales of $9.5 million. Shares were down $1.94 to $9.45.
Shares of Hanger Orthopedic (HGR) rose 8% after the company posted fourth-quarter earnings that topped forecasts by a penny. The company reported a profit of $6.7 million, or 30 cents a share, on sales of $149.2 million. Excluding one-time items, the company earned 14 cents a share. Analysts expected earnings of 13 cents a share. During the year-earlier quarter, the company earned $2.6 million, or 12 cents a share, on sales of $145.9 million. Shares recently had gained 49 cents to $6.75.
Other health care volume movers included Pfizer (PFE), down 19 cents to $26.07; Elan (ELN), up 1 cent to $13; Boston Scientific (BSX), down 26 cents to $23.74; Schering-Plough (SGP), down 18 cents to $18.18; Genta (GNTA), down 10 cents to $2.72; Generex Biotech (GNBT), down 12 cents to $2.19; Johnson & Johnson (JNJ), up 25 cents to $57.91; Novavax (NVAX), down 31 cents to $5.38; Amgen (AMGN), down 23 cents to $75.82; Merck (MRK), up 13 cents to $35.09; and Bristol-Myers Squibb (BMY), down 8 cents to $22.69.
Select the service that is right for you!COMPARE ALL SERVICES
Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
- Weekly roundups
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
- Upgrade/downgrade alerts
Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.
- Diversified model portfolio of dividend stocks
- Alerts when market news affect the portfolio
- Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.
- Real Money + Doug Kass Plus 15 more Wall Street Pros
- Intraday commentary & news
- Ultra-actionable trading ideas
Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.
- 100+ monthly options trading ideas
- Actionable options commentary & news
- Real-time trading community
- Options TV